Lightner AL. Perioperative Management of Biologic and Immunosuppressive
Medications in Patients With Crohn’s Disease. Dis Colon Rectum. 2018 Apr;61(4): 428-431.

EVALUATION AND TREATMENT ALGORITHMS

Further reading: 

Kumar A, Auron M, Aneja A, et al. Inflammatory bowel disease: perioperative pharmacological considerations. Mayo Clin Proc. 2011 Aug;86(8):748-57.

Lightner AL, Shen B. Perioperative use of immunosuppressive medications in patients with Crohn’s disease in the new “biological era”. Gastroenterol Rep (Oxf). 2017 Aug;5(3): 165-177.

Yamamoto T, Spinelli A, Suzuki Y, et al. Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. United European Gastroenterol J. 2016 Dec;4(6):784-793.